Startseite Crystal structure of 1,3,5,7-tetraphenyl-8-(N-phenylformamido)-2-oxa-5-azabicyclo[4.2.0]oct -3-en-7-yl benzoate, C44H34N2O4
Artikel Open Access

Crystal structure of 1,3,5,7-tetraphenyl-8-(N-phenylformamido)-2-oxa-5-azabicyclo[4.2.0]oct -3-en-7-yl benzoate, C44H34N2O4

  • Xue Li , Meng-Meng Zhang , Ying-Zhi Chong , Li-Hua Cui , Yu Ma und Fu-Min Feng ORCID logo EMAIL logo
Veröffentlicht/Copyright: 21. Januar 2020

Abstract

C44H34N2O4, triclinic, P1̄ (no. 2), a = 10.4564(13) Å, b = 11.3627(14) Å, c = 15.3946(19) Å, α = 82.106(2)°, β = 75.318(2)°, γ = 77.704(2)°, V = 1722.0(4) Å3, Z = 2, Rgt(F) = 0.0420, wRref(F2) = 0.1086, T = 296(2) K.

CCDC no.: 1956451

The title crystal structure is shown in the figure. Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colorless block
Size:0.25 × 0.23 × 0.20 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.08 mm−1
Diffractometer, scan mode:Bruker APEX-II, φ and ω-scans
θmax, completeness:25°, >99%
N(hkl)measured, N(hkl)unique, Rint:8883, 6042, 0.020
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 4316
N(param)refined:452
Programs:Bruker programs [1], SHELX [2], [3]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
O10.14510(14)1.08305(11)0.15685(9)0.0523(4)
O20.22295(11)0.68436(10)0.26358(7)0.0337(3)
O30.57113(15)0.76609(15)0.39095(11)0.0676(5)
N10.02029(13)0.89295(12)0.30322(10)0.0347(3)
N20.48491(13)0.74951(13)0.27164(10)0.0361(4)
C1−0.09376(17)0.97957(16)0.34078(12)0.0375(4)
C2−0.0796(2)1.09594(18)0.34658(15)0.0527(5)
H20.0044991.1177880.3267430.063*
C3−0.1910(2)1.1802(2)0.38200(17)0.0669(7)
H3−0.1810681.2585710.3859650.080*
C4−0.3156(2)1.1493(3)0.41128(17)0.0737(8)
H4−0.3898631.2062920.4353160.088*
C5−0.3301(2)1.0343(3)0.40492(16)0.0699(7)
H5−0.4148741.0136350.4234440.084*
C6−0.21958(18)0.9484(2)0.37116(14)0.0511(5)
H6−0.2298170.8696930.3688530.061*
C70.00295(17)0.79503(15)0.26562(11)0.0337(4)
H7−0.0804190.7980960.2534100.040*
C80.09685(16)0.69670(15)0.24562(11)0.0317(4)
C90.22425(16)0.74766(14)0.33813(11)0.0309(4)
C100.14236(15)0.87938(14)0.33365(11)0.0311(4)
H100.1210740.9100660.3931160.037*
C110.07760(17)0.59383(15)0.20555(11)0.0347(4)
C12−0.0167(2)0.60757(19)0.15341(14)0.0531(5)
H12−0.0619470.6845210.1384960.064*
C13−0.0436(2)0.5083(2)0.12364(16)0.0668(7)
H13−0.1079620.5188850.0897780.080*
C140.0239(2)0.3938(2)0.14367(16)0.0633(6)
H140.0047910.3268940.1242390.076*
C150.1196(2)0.37971(18)0.19252(14)0.0514(5)
H150.1666510.3027150.2053040.062*
C160.14716(18)0.47753(16)0.22298(12)0.0409(4)
H160.2131240.4659520.2556420.049*
C170.19536(18)0.66654(15)0.42331(12)0.0363(4)
C180.0679(2)0.6761(2)0.47902(13)0.0527(5)
H18−0.0014320.7359980.4648310.063*
C190.0423(3)0.5979(2)0.55531(15)0.0710(7)
H19−0.0437580.6059840.5925590.085*
C200.1418(3)0.5092(2)0.57654(16)0.0725(7)
H200.1239900.4564730.6280860.087*
C210.2689(3)0.4974(2)0.52167(16)0.0732(7)
H210.3372000.4363160.5358000.088*
C220.2956(2)0.57640(18)0.44533(14)0.0569(6)
H220.3820050.5684380.4086170.068*
C230.52364(16)0.70527(16)0.18346(12)0.0394(4)
C240.5078(2)0.59169(19)0.17261(15)0.0542(6)
H240.4642340.5454040.2211920.065*
C250.5568(2)0.5464(2)0.08941(18)0.0714(7)
H250.5449390.4699090.0819600.086*
C260.6222(2)0.6127(3)0.01820(17)0.0778(8)
H260.6560470.581068−0.0374480.093*
C270.6379(2)0.7256(3)0.02858(16)0.0745(7)
H270.6822870.771074−0.0202280.089*
C280.5885(2)0.7730(2)0.11104(14)0.0560(6)
H280.5989810.8502690.1177080.067*
O40.28409(11)0.90589(10)0.18084(7)0.0347(3)
C290.27291(16)0.92363(15)0.27345(11)0.0318(4)
C300.58476(19)0.73755(19)0.31617(16)0.0507(5)
H300.6712610.7043410.2861250.061*
C310.20647(17)0.98676(16)0.13248(12)0.0371(4)
C320.20940(17)0.94044(17)0.04661(12)0.0395(4)
C330.2455(2)0.81899(19)0.03327(14)0.0527(5)
H330.2770830.7636410.0769440.063*
C340.2344(3)0.7798(2)−0.04537(16)0.0720(7)
H340.2552360.697697−0.0532880.086*
C350.1929(3)0.8612(3)−0.11157(16)0.0767(8)
H350.1878920.834554−0.1648670.092*
C360.1592(3)0.9808(3)−0.09926(16)0.0782(8)
H360.1319081.035990−0.1445290.094*
C370.1651(2)1.0213(2)−0.01999(14)0.0599(6)
H370.1391971.103210−0.0114190.072*
C380.31286(17)1.03919(15)0.28575(13)0.0367(4)
C390.2720(2)1.08800(18)0.36819(14)0.0495(5)
H390.2142721.0518490.4155630.059*
C400.3155(2)1.1897(2)0.38131(18)0.0623(6)
H400.2863431.2213980.4370680.075*
C410.4006(2)1.2435(2)0.3132(2)0.0677(7)
H410.4286911.3124570.3218310.081*
C420.4446(2)1.1952(2)0.23170(19)0.0685(7)
H420.5040731.2309510.1853210.082*
C430.4016(2)1.09361(18)0.21746(15)0.0519(5)
H430.4325161.0618370.1617620.062*
C440.35038(15)0.80638(14)0.31557(11)0.0316(4)
H440.3584590.8272050.3734070.038*
  1. aOccupancy: 0.854(7).

Source of material

A mixture of 1.55 g (4.7 mmol) of diphenacylaniline and 0.87 mL (9.4 mmol) of POCl3 in 30 mL of pyridine (dried over CaH2) was heated with occasional swirling at 373 K for 45 min. The deep red solution was poured onto 50 mL of crushed ice and the resulting soild was filtered. Two recrystallizations from isopropyl alcohol gave 0.81 g (55%) of red needles (2,4,6-triphenyl-1,4-oxazine) [4]. The oxazine was placed in a quartz tube with an equal proportion of methanol and tetrahydrofuran (30 mL), and irradiated by a blue LED for light reaction for 5 hours. The product was obtained by column chromatography, and the developing solvent was petroleum ether and ethyl acetate 30:1. Finally, the resulting solution was evaporated to dryness in vacuo to give the title compound as a colorless crystal.

Experimental details

All hydrogen atoms were placed in the calculated positions and all the non-hydrogen atoms were refined anisotropically.

Discussion

Photochemical reaction is a widely used method in organic synthesis. Many photosensitive compounds such as 1,4-dihydropyridines [5], 1,4-dihydropyrazines [6] and 1,4-oxazines are used as raw materials for [2 + 2] Photocyclization. The 1,4-oxazine is among the simplest heterocyclic compounds to be so far unknown. A fair number of substituted and ring-fused 1,4-oxazines have been prepared [7], which have abundant pharmacological activities and used as central nervous system agonists [8] and selective serotonin reuptake inhibitors [9].

In the molecules forming the title crystal structure, the rings of oxazine and four membered ring are not planar due to the steric hindrance of phenyl substituents (see the figure). In the four membered ring, the C9–C10, C10–C29, C29–C44 and C44–C9 bond lengths are of 1.560(2), 1.581(2), 1.556(2) and 1.544(2) Å, respectively. Several important bond angle data are involved as follows C7–N1–C10 = 116.67(13)°, C8–O2–C9 = 114.37(12)°, C30–N2–C44 = 117.94(16)°. The bond lengths and angles are in the expected ranges.

References

1. BRUKER. SAINT. Version 8.23B., Bruker AXS Inc., Madison, WI, USA (2013).Suche in Google Scholar

2. Sheldrick, G. M.: Crystal structure refinement with SHELXL. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053229614024218Suche in Google Scholar PubMed PubMed Central

3. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Suche in Google Scholar PubMed

4. Correia, J.: Synthesis of 2, 4, 6-triphenyl-1, 4-oxazine. J. Org. 38 (1973) 3433–3434.10.1021/jo00959a051Suche in Google Scholar

5. Zhong, Q.; Fan, Q.; Yan, H.: Synthesis of 2,3-dihydropyrroles by photo rearrangement of Hantzsch 1,4-dihydropyridines with high diastereoselectivity. Tetrahedron Lett. 58 (2017) 1292–1295.10.1016/j.tetlet.2017.02.041Suche in Google Scholar

6. Xin, H.; Sun, W.; Yan, H.: Photochemical ring contraction of 1-aryl-1,4-dihydropyrazine to 1-aryl-1H-imidazole. J. Photochem. Photobiol. A. 267 (2013) 49–54.10.1016/j.jphotochem.2013.06.010Suche in Google Scholar

7. Aitken, R. A.; Aitken, P. G.; Carruthers, P. G.; Jean, M. A.; Slawin, A. M.: 1,4-oxazine. Chem. Commun. 49 (2013) 11367–11369.10.1039/c3cc47801gSuche in Google Scholar PubMed

8. Nozulak, J.; Vigouret, J. M.; Jaton, A. L.: Centrally Acting α 1-Adrenoceptor agonists based on hexahydronaphth[2,3-b]-1,4-oxazines and octahydrobenzo[g]quinolines. J. Med. Chem. 35 (1992) 480–489.10.1021/jm00081a008Suche in Google Scholar PubMed

9. Zhou, D.; Harrison, B. L.; Shah, U.: Studies toward the discovery of the next generation of antidepressants. Part 5: 3,4-Dihydro-2H-benzo[1,4]oxazine derivatives with dual 5-HT1A receptor and serotonin transporter affinity. Bioorg. Med. Chem. Lett 16 (2006) 1338–1341.10.1016/j.bmcl.2005.11.054Suche in Google Scholar

Received: 2019-10-28
Accepted: 2019-12-28
Published Online: 2020-01-21
Published in Print: 2020-04-28

©2020 Xue Li et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 Public License.

Artikel in diesem Heft

  1. Frontmatter
  2. Crystal structure of catena-poly[(μ2-3-(benzo[d]thiazol-2-yl)-5-carboxybenzoato-κ2N:O)silver(I)], C15H8AgNO4S
  3. Crystal structure of bis(4-phenylpiperazin-1-ium) bis(2-(4-phenylpiperazin-1-yl)succinato-κ2O,O′)copper(II) tetrahydrate, C48H70CuN8O12, [C10H14N2]2[Cu(C14H17N2O4)2] ⋅ 4 H2O
  4. Crystal structure of triaqua-bis(2-(6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydronaphthalen-1-yl)-1-(2-oxo-2,5-dihydrofuran-3-yl)ethane-1-sulfonato-κ2O,O′)calcium(II) – ethanol (1/2), C44H76CaO19S2
  5. The crystal structure of ethyl 5-(4-(diphenylamino)phenyl)thiophene-2-carboxylate, C25H21NO2S
  6. The crystal structure of 5-bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine, C7H6BrN5
  7. The crystal structure of (E)-5-chloro-2-hydroxy-N′-(2-hydroxy-4-methoxybenzylidene)benzohydrazide, C15H13ClN2O4
  8. The crystal structure of (2Z,2′Z)-N′,N′′′′-(pyridine-2,6-dicarbonyl)dipicolinohydrazonamide, C19H17N9O2
  9. Photochromic properties and crystal structure of 3,3′-(perfluorocyclopent-1-ene-1,2-diyl)bis(5-(4-(azidomethyl)phenyl)-2-methylthiophene), C29H20F6N6S2
  10. Crystal structure of aqua-dichlorido-(4-(((3-ethoxy-2-oxidobenzylidene)hydrazono)(oxido)methyl)pyridin-1-ium-κ3N,O,O′)iron(III), C15H16Cl2N3O4Fe
  11. Crystal structure of catena-poly[diaqua-(μ2-4,4′-bipyridine-κ2N:N′)-bis(2,3,4,5-tetrabromo-6-carboxybenzoato-κ1O)-nickel(II)], C26H14Br8NiN2O10
  12. Crystal structure of diethanol-κ1O-bis(μ2-N-((2-oxidonaphthalen-1-yl)methylene)pyrazine-2-carbohydrazonato-κ5N,O,O′:O′:N′)-bis(nitrato-κ2O,O′)dieuropium(III), C36H32N10O12Eu2
  13. The crystal structure of 2-aminoisophthalic acid, C8H7NO4
  14. Crystal structure of (E)-2-(4-((3,4-difluorobenzyl)oxy)styryl)-4,6-dimethoxybenzaldehyde, C24H20F2O4
  15. Crystal structure of 2-benzoylpyrene, C23H14O
  16. Crystal structure of chlorido-(η6-p-cymene)-(N-(2-fluorophenyl)-1-(pyridin-2-yl)methanimine-κ2N,N′)ruthenium(II) – acetone (1/1), C22H23ClN2F7OPRu
  17. The crystal structure of 2-bromoisonicotinic acid, C6H4BrNO2
  18. Crystal structure of 1,3,5,7-tetraphenyl-8-(N-phenylformamido)-2-oxa-5-azabicyclo[4.2.0]oct -3-en-7-yl benzoate, C44H34N2O4
  19. Synthesis and crystal structure of 4-(3-acetyl-5-(thiophen-2-yl)-2,3-dihydro-1,3,4-oxadiazol-2-yl)-7-(diethylamino)-2H-chromen-2-one, C21H21N3O4S
  20. Crystal structure of poly[diaqua-(μ2-4,4′-bipyridine-κ2N:N′)-(μ2-3,4,5,6-tetrafluorophthalato-κ2O:O′)nickel(II)], C18H12F4NiN2O6
  21. Crystal structure of 4-hydroxynaphtho[2,3-b]benzofuran-6,11-dione, C16H8O4
  22. The crystal structure of 3,10-bis(4-methoxyphenyl)-6,12-dibenzyl-2,9-acetyl-6,12-diazapentacyclo[6.3.1.02,7.04,11.05,9]dodecane – acetone (1/1), C45H48N2O5
  23. The crystal structure of (E)-2-(((2-(1H-indol-3-yl)ethyl)iminio)methyl)-6-bromophenolate, C17H15N2BrO
  24. Crystal structure of catena-poly[diaqua-(μ2-oxalyl dihydrazide-κ4N,O:N′,O′)-bis(μ2-pyridine-2,3-dicarboxylato-κ3N,O,O′)dicadmium(II)] hexahydrate, C16H28O18N6Cd2
  25. Crystal structure of poly[tetra-(μ4-naphthalene-1,8-dicarboxylato-κ4O:O,O′: O′′:O′′,O′′′)-(μ4-oxo-κ4O:O:O:O) penta-lead(II)], C48H24O17Pb5
  26. Crystal structure of 5H-dibenzo[c,f][1,5]oxabismocin-12 (7H)-yl acetate, C16H15O3Bi
  27. The crystal structure of 2-(4-chloro-6-nitrophenyl)-1-(4-chloro-3-nitrophenyl)diazene 1-oxide, C12H6Cl2N4O5
  28. Crystal structure of bis(3-methyl-N-(1-(pyrazin-2-yl)ethylidene)benzohydrazonato-κ3O,N,N′)nickel(II), C28H26N8O2Ni
  29. Crystal structure of 3,10-bis(4-chlorophenyl)-6,12-dibenzyl-2,9-acetyl-6,12-diazapentacyclo[6.3.1.02,7.04,11.05,9]-dodecane, C40H36Cl2N2O2
  30. Crystal structure of bis[(μ2-4⋯O,O′:O′)-(4-hydroxybenzoato-κ2O,O′)-(1,10-phenanthroline-κ2N,N′)]-di-lead(II)μ-4-hydroxybenzoato-κ3O,O′:O′3O,O′:O′-bis-[(4-hydroxybenzoato-κ2O,O′)bis(1,10-phenanthroline-κ2N,N′)di-lead(II)] monohydrate, C52H36N4O12Pb2 ⋅ H2O
  31. Crystal structure of poly[diaqua-(μ3-3,4,5,6-tetrafluoro-phthalato-κ3O:O′:O′′)-(μ2-1,2-bis(4-pyridyl)ethene-κ2N:N′)cobalt(II)], C14H9CoF4NO6
  32. Crystal structure of 7-hydroxy-4-phenyl-2H-chromen-2-one, C15H10O3
  33. Crystal structure of 3,7-dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione 4-hydroxybenzoic acid, C20H24N4O6
  34. Crystal structure of catena-poly[(μ2-1,5-dimethyl-2-phenyl-4-((pyridin-4-ylmethylene)amino)-1,2-dihydro-3H-pyrazol-3-one-κ2N:O)-bis(nitrato-κ1O)zinc(II)], C17H16N6O7Zn
  35. The crystal structure of diaqua-bis(6-aminopicolinato-κ2N,O)magnesium(II), C12H14O6N4Mg
  36. Crystal structure of (pyridine-2-carboxamide-κ2N,O)-[tris((1H-benzo[d]imidazol-2-yl)methyl)amine-κ4N,N′,N′′,N′′′]nickel(II) diperchlorate — methanol (1/3), C33H39Cl2N9NiO12
  37. Crystal structure of catena-poly[diaqua-bis(3-(4-trifluoromethyl-phenyl)-acrylato-κO1)-(μ2-1,4-bis(1-imidazolyl)benzene-κ2N3:N3)cobalt(II)], C32H26CoF6N4O6
  38. Crystal structure of (E)-3-(2-(2-hydroxy-4-methoxystyryl)-3,3-dimethyl-3H-indol-1-ium-1-yl)propane-1-sulfonate monohydrate, C22H25NO5S⋅H2O
  39. The crystal structure of bis(N-oxy-2-(1H-tetrazol-1-yl) acetamide κ2O,O′)-diaqua-zinc(II), C6H12ZnN10O6
  40. Crystal structure of (E)-4-((4-chlorophenylimino)methyl)pyridinium 3,5-dinitrobenzoate, C19H13ClN4O6
  41. Crystal structure of dichlorido-bis((E)-2-((pyridin-4-ylmethylene)amino)phenol)zinc(II), C24H20Cl2N4O2Zn
  42. Crystal structure of cyclo-[tetrachlorido-bis(μ2-p-xylylenediamine-κ2N:N′)dipalladium(II)] dimethyl sulfoxide solvate, C20H36Cl4N4O2Pd2S2
  43. Crystal structure of 4-(3-fluorophenyl)-7-hydroxy-2H-chromen-2-one, C15H9FO3
  44. Crystal structure of (E)-2-((2-(pyrimidin-2-yl)hydrazono)methyl)quinolin-1-ium perchlorate – methanol (1/1), C15H16N5O5Cl
  45. The crystal structure of bis(N-(amino(pyridin-2-yl)methylene)-5-chloro-2-hydroxybenzohydrazonato-κ3N,N′,O)zinc(II) – methanol (2/5), C57H60Cl2N16O13Zn2
  46. Synthesis and crystal structure of 4,4′-di(4-pyridyl)-6,6′-di(tert-butyl)-2,2′-[propylenedioxybis(nitrilomethylidyne)]diphenol, C35H40N4O4
  47. Crystal structure of (3E,3′E)-3,3′-((1,3,4-thiadiazole-2,5-diyl)bis(sulfanediyl))bis(4-hydroxy-4-phenylbut-3-en-2-one), C22H18N2O4S3
  48. Crystal structure of (N-benzyl-N-methyl-dithiocarbamato-κ2S,S′)di(4-chlorobenzyl)chloridotin(IV), C23H22Cl3NS2Sn
  49. Crystal structure of (1,4,7,10,13,16-hexaoxacyclooctadecane-κ6O6) sodium bromide hydrate, [Na(18-crown-6)]Br ⋅ H2O, C12H26BrNaO7
  50. Crystal structure of 7-ethoxyl-6,8-difluoro-4-oxo-1-phenyl-1,4-dihydro-quinoline-3-carboxylic acid, C18H13F2N1O4
  51. Crystal structure of chlorido (2-(4-ethylphenyl)pyrimidine-k2C,N)(triphenylphosphane-kP) palladium(II), C30H26ClN2PPd
  52. Crystal structure of 18-crown-6 – 1,4-diiodotetrafluorobenzene – acetonitrile (1/1/2), C22H30F4I2N2O6
  53. Crystal structure of diisobutyl 2,5-dihydroxycyclohexa-1,4-diene-1,4-dicarboxylate, C16H24O6
  54. Crystal structure of poly[[tris(μ2-cis-1,2-cyclohexanedicarboxylato)-κ2O, O′]-bis[μ3-1,3,5-tris[(1H-imidazol-1-yl)methyl]benzene-κ3N, N′,N′′]-trizinc(II)] – water (1/20), C60H106N12O32Zn3
  55. The synthesis and crystal structure of 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-((trifluoromethyl)sulfinyl)-1H-pyrazole-3-carboxamide–tetrahydrofuran (1/1), C16H14N4Cl2F6O3S
  56. Crystal structure of dimethylbis(diisopropyldithiocarbamato-κ2S,S′)tin(IV), C16H34N2S4Sn
  57. Crystal structure of diisopropyl 2,5-dihydroxycyclohexa-1,4-diene-1,4-dicarboxylate, C14H20O6
  58. The synthesis and crystal structure of ethyl (E)-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-5-((2-methoxybenzylidene)amino)-4-((trifluoromethyl)sulfinyl)-1H-pyrazole-3-carboxylate, C22H15N3Cl2F6O4S
  59. The crystal structure of a matrine derivative, 13-(methylamine-1-yl) carbodithioate matrine, C17H27N3OS2
  60. Crystal structure of bis(2-hydroxy-6-((phenylimino)methyl)phenolato-κ2N,O)copper(II), C26H20CuN2O4
  61. The crystal structure of 2-p-fluorophenyl-5-dihydroxymethyl-1,3,4-oxadiazole, C9H7FN2O3
  62. Crystal structure of dichloridobis(4-chlorophenyl-κC1)(1,10-phenanthroline-κ2N,N′)tin(IV), C24H16Cl4N2Sn
  63. Crystal structure of bis{bromido-triphenyltin(IV)}(μ2-[4,4′-bipyridine]1,1′-dioxide-κ2O:O′), C46H38Br2N2O2Sn2
  64. Crystal structure of 2-(5-chloro-quinolin-8-yloxy)-N-quinolin-8-yl-acetamide, C20H14N3O2Cl
  65. Crystal structure of bis(N-(1-(3-ethylpyrazin-2-yl)ethylidene)-3-hydroxy-2-naphthohydrazonato-κ3N,N′,O)cobalt(II) — dimethylformamide (1/1), C41H41N9O5Co
  66. Crystal structure of bis[2-(1-(3-ethylpyrazin-2-yl)ethylidene)-1-tosylhydrazin-1-ido-κ3-N,N′,O]copper(II), C30H34N8O4S2Cu
  67. Crystal structure of (2-p-tolylpyrimidine-κ2C,N)(triphenylphosphane-κP) palladium(II), C29H24ClN2PPd
  68. Halogen bonding in crystal structure of bis(1,4,7,10-tetraoxacyclododecane-κ4O,O′,O′′,O′′′)cesium triiodide, C16H32CsI3O8
  69. The synthesis and crystal structure of N-(3-cyano-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-(trifluoromethylsulfinyl)-1H-pyrazol-5-yl)-2-phenylacetamide, C20H10N4Cl2F6O2S
  70. The crystal structure of 4-(trifluoromethyl)nicotinic acid, C7H4F3NO2
  71. Crystal structure of 3-(2-methylbenzyl)thiazolidin-2-one, C11H13ONS
  72. The crystal structure of 2,2,2-trifluoro-1-(isoquinolin-1-yl)ethane-1,1-diol, C11H8F3NO2
  73. The crystal structure of 3-bromoisonicotinic acid, C6H4BrNO2
  74. The crystal structure of 5-nitropicolinic acid monohydrate, C6H6N2O5
  75. The crystal structure of 3-(4-hydroxybenzyl)-1,5-dioxaspiro[5.5]undecane-2,4-dione, C16H18O5
  76. Crystal structure of [[Mo3Se7(S2CNEt2)3]2(μ-Se)] ⋅ 2(C6H4Cl2), C42H68Cl4Mo6N6S12Se15
  77. Crystal structure of (E)-4-hydroxy-3-((5-phenyl-1,3,4-oxadiazol-2-yl)thio)pent-3-en-2-one, C13H12N2O3S
  78. The crystal structure of (2,3-dioxo-5,6:13,14-dibenzo-9,10-benzo-1,4,8,11-7, 11-diene-κ4N,N′,N′′,N′′′)-nickel(II), Ni(C22H14N4O2)
  79. Crystal structure of 3-(1-benzyl-2-ethyl-4-nitro-1H-imidazol-5-ylthio)-propanoic acid, C15H17N3O4S
  80. The crystal structure of dichlorobis(2-(dicyclohexylphosphino)-2′,4′,6′-tri-i-propyl-1,1′-biphenyl) palladium(II)-dichloroform, C68H100Cl8P2Pd
  81. Crystal structure and antimicrobial properties of (1,4,7,10-tetraoxacyclododecane-κ4O,O′,O′′,O′′′)cesium(I) pentaiodide, C16H32CsI5O8
Heruntergeladen am 30.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2019-0799/html
Button zum nach oben scrollen